Cargando…

Fecal Microbial Transplants Reduce Antibiotic-resistant Genes in Patients With Recurrent Clostridium difficile Infection

Background. Recurrent Clostridium difficile infection (RCDI) is associated with repeated antibiotic treatment and the enhanced growth of antibiotic-resistant microbes. This study tested the hypothesis that patients with RCDI would harbor large numbers of antibiotic-resistant microbes and that fecal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Millan, Braden, Park, Heekuk, Hotte, Naomi, Mathieu, Olivier, Burguiere, Pierre, Tompkins, Thomas A., Kao, Dina, Madsen, Karen L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Articles and Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885654/ https://www.ncbi.nlm.nih.gov/pubmed/27025836 http://dx.doi.org/10.1093/cid/ciw185

Ejemplares similares

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence
por: Gerding, Dale N, et al.
Publicado: (2018)

Fecal Transplantation for the Treatment of Recurrent Clostridium Difficile Infection
por: Karadsheh, Zeid, et al.
Publicado: (2013)

Recent Progress for the Effective Prevention and Treatment of Recurrent Clostridium difficile Infection
por: Ramsay, Isobel, et al.
Publicado: (2018)

Weight Changes in Fecal Microbiota Transplant for Clostridium difficile
por: Hussam, Dina, et al.
Publicado: (2017)

Dynamics of the fecal microbiome in patients with recurrent and nonrecurrent Clostridium difficile infection
por: Seekatz, Anna Maria, et al.
Publicado: (2016)

Lyophilized Fecal Microbiota Transplantation Capsules for Recurrent Clostridium difficile Infection
por: Dupont, Hebert, et al.
Publicado: (2017)

Clostridium difficile: the increasingly difficult pathogen
por: Pop-Vicas, Aurora, et al.
Publicado: (2008)

Fecal microbiota transplantation for recurrent Clostridium difficile infection: Experience, protocol, and results
por: Reigadas, Elena, et al.
Publicado: (2018)

Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation
por: Staley, Christopher, et al.
Publicado: (2018)

Fecal Microbiota Transplant in Recurrent Clostridium Difficile Infections: A Systematic Review
por: Gupta, Kunal, et al.
Publicado: (2022)

618. Do Clinical Factors Affect Microbial Engraftment After Fecal Microbiota Transplantation in Recurrent Clostridium difficile Infection?
por: Budree, Shrish, et al.
Publicado: (2018)

Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
por: Song, Yang, et al.
Publicado: (2013)

Recurrent Clostridium difficile infection treated with home fecal transplantation: a case report
por: Duke, Pauline S, et al.
Publicado: (2014)

Fecal Microbiota Transplantation by Freeze-Dried Oral Capsules for Recurrent Clostridium difficile Infection
por: Hecker, Michelle T., et al.
Publicado: (2016)

Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection
por: Youngster, Ilan, et al.
Publicado: (2016)

Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity
por: Carlucci, Christian, et al.
Publicado: (2016)

Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis
por: Nanki, Kosaku, et al.
Publicado: (2018)

Engraftment and Augmentation of Microbiome Following Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
por: Lee, Christine, et al.
Publicado: (2017)

Fecal Microbiota Transplantation in Recurrent Clostridium Difficile Infection: Is it Superior to Other Conventional Methods?
por: Lin, Zayar, et al.
Publicado: (2020)

Genome-Based Infection Tracking Reveals Dynamics of Clostridium difficile Transmission and Disease Recurrence
por: Kumar, Nitin, et al.
Publicado: (2016)

Impact of Tigecycline Versus Other Antibiotics on the Fecal Metabolome and on Colonization Resistance to Clostridium difficile in Mice
por: Jump, Robin L.P., et al.
Publicado: (2017)

Timing of Tributyrin Supplementation Differentially Modulates Gastrointestinal Inflammation and Gut Microbial Recolonization Following Murine Ileocecal Resection
por: Mocanu, Valentin, et al.
Publicado: (2021)

Roux-en-Y gastric bypass and sleeve gastrectomy induce substantial and persistent changes in microbial communities and metabolic pathways
por: Dang, Jerry T., et al.
Publicado: (2022)

Correction: Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
Publicado: (2014)

Is a Single Fecal Microbiota Transplant a Promising Treatment for Recurrent Clostridium difficile Infection?
por: Hota, Susy S, et al.
Publicado: (2018)

Cost Effectiveness Analysis of Fecal Transplant Delivery Methods for Recurrent Clostridium difficile Infections in Outpatients
por: Walker, Jeremey, et al.
Publicado: (2017)

Is it reasonable to perform Fecal Microbiota Transplantation for recurrent Clostridium difficile Infection in patients with liver cirrhosis?
por: Olmedo, Maria, et al.
Publicado: (2019)

In Silico Analysis of Changes in Predicted Metabolic Capabilities of Intestinal Microbiota after Fecal Microbial Transplantation for Treatment of Recurrent Clostridioides difficile Infection
por: Dahiya, Monica, et al.
Publicado: (2023)

Clostridium difficile and Antibiotic-associated Diarrhea
por: Bhattacharyya, Mahuya, et al.
Publicado: (2020)

Antibiotics Associated With Clostridium difficile Infection
por: Rafey, Abdur, et al.
Publicado: (2023)

Fecal Calprotectin Level Reflects the Severity of Clostridium difficile Infection
por: Kim, Jieun, et al.
Publicado: (2017)

Patient Perspectives on Fecal Microbiota Transplantation for Clostridium Difficile Infection
por: Zellmer, Caroline, et al.
Publicado: (2016)

Tea and Recurrent Clostridium difficile Infection
por: Oman Evans II, Martin, et al.
Publicado: (2016)

Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States
por: Zhang, Dongmu, et al.
Publicado: (2018)

Fecal Bacteriotherapy: A Case Report in an Immunosuppressed Patient with Ulcerative Colitis and Recurrent Clostridium difficile Infection
por: Zainah, Hadeel, et al.
Publicado: (2012)

Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection
por: Hirsch, Bruce E, et al.
Publicado: (2015)

Antimicrobial Resistance Gene Acquisition and Depletion Following Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
por: Leung, Victor, et al.
Publicado: (2018)

Cost-Effectiveness of Fecal Microbiota Transplantation in the Treatment of Recurrent Clostridium Difficile Infection: A Literature Review
por: Arbel, Leor T, et al.
Publicado: (2017)

Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children
por: Fareed, Shaaz, et al.
Publicado: (2018)

Clinical Efficacy and Microbiome Changes Following Fecal Microbiota Transplantation in Children With Recurrent Clostridium Difficile Infection
por: Li, Xiaolu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1nhao1rstebjr2vkj765qbr3va